Search Results - "Nakorn, Thanyaphong Na"

Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment by Richardson, Paul G., Hungria, Vânia T.M., Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios Athanasios, Elghandour, Ashraf, Jedrzejczak, Wieslaw W., Guenther, Andreas, Nakorn, Thanyaphong Na, Siritanaratkul, Noppadol, Schlossman, Robert L., Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae Hoon, Einsele, Hermann, Sopala, Monika, Bengoudifa, Bourras-Rezki, Corrado, Claudia, Binlich, Florence, San-Miguel, Jesús F.

“…Panobinostat is a potent pan-deacetylase inhibitor that affects the growth and survival of multiple myeloma (MM) cells through alteration of epigenetic…”
Get full text

Prevalence of monoclonal gammopathy of undetermined significance in Thailand by Watanaboonyongcharoen, Phandee, Nakorn, Thanyaphong Na, Rojnuckarin, Ponlapat, Lawasut, Panisinee, Intragumtornchai, Tanin

“…Individuals with monoclonal gammopathy of undetermined significance (MGUS) develop multiple myeloma and related malignancies at the rate of 1% per year. Given…”
Get full text

Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial by San‐Miguel, Jesús F., Hungria, Vania T. M., Yoon, Sung‐Soo, Beksac, Meral, Dimopoulos, Meletios A., Elghandour, Ashraf, Jedrzejczak, Wieslaw W., Guenther, Andreas, Na Nakorn, Thanyaphong, Siritanaratkul, Noppadol, Schlossman, Robert L., Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae‐Hoon, Einsele, Hermann, Salwender, Hans, Sopala, Monika, Redhu, Suman, Paul, Sofia, Corrado, Claudia, Richardson, Paul G.

“…Summary Panobinostat in combination with bortezomib and dexamethasone demonstrated a significant and clinically meaningful progression‐free survival benefit…”
Get full text

Characterization of Mouse Clonogenic Megakaryocyte Progenitors by Nakorn, Thanyaphong Na, Miyamoto, Toshihiro, Weissman, Irving L.

“…Although it has been shown that unfractionated bone marrow, hematopoietic stem cells, common myeloid progenitors, and bipotent megakaryocyte/erythrocyte…”
Get full text

Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma by Intragumtornchai, Tanin, Bunworasate, Udomsak, Na Nakorn, Thanyaphong, Rojnuckarin, Ponlapat

“…With currently available combination chemotherapy regimens, the outcome of the patients newly diagnosed with aggressive non-Hodgkin's lymphoma (NHL) identified…”
Get full text

Parvovirus B19 infection in HIV patient with pure red cell aplasia by SANPHASITVONG, Wanviput, POOVORAWAN, Kittiyod, BOONSUK, Pitirat, ASSANASEN, Thamathorn, NAKORN, Thanyaphong Na, POOVORAWAN, Yong

“…Anemia in HIV-infected patients is a common clinical manifestation. We report on a 31-year-old Thai male, who had been HIV positive for 6 years, did not harbor…”
Get full text

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial by Gay, Francesca, Weisel, Katja Christina, Goldschmidt, Hartmut, Maisnar, Vladimir, Moreau, Philippe, Pluta, Agnieszka, Chng, Wee-Joo, Kaiser, Martin, Zweegman, Sonja, Spencer, Andrew, Skacel, Tomas, Palumbo, Antonio, Labotka, Richard, Fantl, Dorotea, Horvath, Neomi, Lee, Cindy, Taylor, Kerry, Spencer, Andrew, Agis, Hermine, Zojer, Niklas, Offner, Fritz, Wu, Ka Lung, Zanella, Karla, Capra, Marcelo, Araújo, Sérgio, Gregora, Evzen, Hajek, Roman, Maisnar, Vladimir, Scudla, Vlastimil, Spicka, Ivan, Abildgaard, Niels, Andersen, Niels, Jensen, Bo Amdi, Plesner, Torben, Salomo, Morten, Svirskaite, Asta, Moreau, Philippe, Goldschmidt, Hartmut, Schieferdecker, Aneta, Zeis, Matthias, Klein, Stefan, Reimer, Peter, Hoffmann, Martin, Kyrtsonis, Mary-Christine, Anagnostopoulos, Achilleas, Illés, Árpád, Borbényi, Zita, Mikala, Gabor, Dally, Najib, Horowitz, Netanel, Gutwein, Odit, Nemets, Anatoly, Vaxman, Iuliana, Trestman, Svetlana, Preis, Meir, Rossi, Giuseppe, Liberati, Anna Marina, Bosi, Alberto, Nakaseko, Chiaki, Matsumoto, Morio, Nagai, Hirokazu, Sunami, Kazutaka, Chou, Takaaki, Akashi, Koichi, Eom, Hyeon Seok, Min, Chang Ki, Yoon, Sung Soo, Kim, Kihyun, Vellenga, Edo, Grosicki, Sebastian, Pluta, Andrzej, Robak, Tadeusz, Bergantim, Rui, Goh, Yeow Tee, McDonald, Andrew, Rapoport, Bernado, Álvarez Rivas, Miguel Angel, De Arriba de La Fuente, Felipe, Mateos, Maria Victoria, Oriol Rocafiguera, Albert, San Miguel, Jesús, Alegre-Amor, Adrian, Axelsson, Per, Carlson, Kristina, Stromberg, Olga, Hansson, Markus, Liu, Ta-Chih, Huang, Shang-Yi, Unal, Ali, Goker, Hakan, Sonmez, Mehmet, Korenkova, Sybiryna, Oakervee, Heather, Sati, Hamdi, Benjamin, Reuben, Garg, Mamta, Cook, Gordon, Jenner, Matthew, Berryman, Robert, Janakiram, Murali

“…Maintenance therapy following autologous stem cell transplantation (ASCT) can delay disease progression and prolong survival in patients with multiple myeloma…”
Get full text

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial by San-Miguel, Jesús F, Prof, Hungria, Vânia T M, MD, Yoon, Sung-Soo, Prof, Beksac, Meral, Prof, Dimopoulos, Meletios Athanasios, Prof, Elghandour, Ashraf, Prof, Jedrzejczak, Wieslaw Wiktor, Prof, Günther, Andreas, MD, Nakorn, Thanyaphong Na, MD, Siritanaratkul, Noppadol, MD, Corradini, Paolo, Prof, Chuncharunee, Suporn, MD, Lee, Je-Jung, Prof, Schlossman, Robert L, MD, Shelekhova, Tatiana, PhD, Yong, Kwee, Prof, Tan, Daryl, MRCP, Numbenjapon, Tontanai, MD, Cavenagh, Jamie D, MD, Hou, Jian, Prof, LeBlanc, Richard, MD, Nahi, Hareth, Prof, Qiu, Lugui, Prof, Salwender, Hans, MD, Pulini, Stefano, MD, Moreau, Philippe, Prof, Warzocha, Krzysztof, Prof, White, Darrell, Prof, Bladé, Joan, MD, Chen, WenMing, Prof, de la Rubia, Javier, Prof, Gimsing, Peter, MD, Lonial, Sagar, Prof, Kaufman, Jonathan L, MD, Ocio, Enrique M, MD, Veskovski, Ljupco, MD, Sohn, Sang Kyun, Prof, Wang, Ming-Chung, MD, Lee, Jae Hoon, Prof, Einsele, Hermann, Prof, Sopala, Monika, PhD, Corrado, Claudia, MD, Bengoudifa, Bourras-Rezki, MS, Binlich, Florence, MD, Richardson, Paul G, Prof

“…Summary Background Panobinostat is a potent oral pan-deacetylase inhibitor that in preclinical studies has synergistic anti-myeloma activity when combined with…”
Get full text

A Prospective Multicenter Open-Label Study of the Effectiveness of Epoetin Beta for Patients with Low/Intermediate-1-Risk Myelodysplastic Syndrome (MDS): A Preliminary Result by Chuncharunee, Suporn, Kanitsap, Nonglak, Suwanban, Tawatchai, Khuhapinant, Archrob, Uaprasert, Noppacharn, Chansung, Kanchana, Rattarittamrong, Ekarat, Wongkhantee, Somchai, Siritanaratanakul, Noppadol, Norasetthada, Lalita, Na Nakorn, Thanyaphong, Charnwiboonsri, Chadchai

“…Introduction : Chronic anemia impairs quality of life and adversely affects survival in patients with MDS. Recombinant erythropoietin (EPO) has been proven in…”
Get full text

Hepatitis B Surface Antigen Seropositivity and Low Body Weight Are Correlated with Asymptomatic Neutropenia In the Thai Population by Lawasut, Panisinee, Nakorn, Thanyaphong Na, Rojnuckarin, Ponlapat, Intragumtornchai, Tanin

“…Abstract 4751 The etiology of asymptomatic neutropenia is unknown. We have conducted a community-based study to determine predisposing factors for asymptomatic…”
Get full text

Final Analysis of Overall Survival from the Phase 3 Panorama 1 Trial of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma by San-Miguel, Jesús F., Hungria, Vania T.M., Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A., Elghandour, Ashraf, Jedrzejczak, Wieslaw W., Guenther, Andreas, Nakorn, Thanyaphong Na, Siritanaratkul, Noppadol, Schlossman, Robert L., Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae Hoon, Einsele, Hermann, Sopala, Monika, Bengoudifa, Bourras-Rezki, Corrado, Claudia, Richardson, Paul G.

“…Introduction: Panobinostat is a potent pan-deacetylase inhibitor (pan-DACi) that targets key aberrations in multiple myeloma (MM) cell biology, including…”
Get full text

Analysis of Outcomes Based on Response in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma Treated with Panobinostat or Placebo in Combination with Bortezomib and Dexamethasone in the Panorama 1 Trial: Updated Analysis Based on Prior Treatment by San Miguel, Jesús F, Hungria, Vânia TM, Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A., Elghandour, Ashraf, Jedrzejczak, Wieslaw W., Guenther, Andreas, Nakorn, Thanyaphong Na, Siritanaratkul, Noppadol, Schlossman, Robert L., Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae Hoon, Einsele, Hermann, Sopala, Monika, Bengoudifa, Bourras-Rezki, Corrado, Claudia, Binlich, Florence, Richardson, Paul G.

“…Introduction: Panobinostat (PAN), a potent pan-deacetylase inhibitor, was the first agent of its class to produce a statistically significant and clinically…”
Get full text

Low Prevalence of Asymptomatic Neutropenia in Thailand by Lawasut, Panisinee, Nakorn, Thanyaphong Na, Rojnuckarin, Ponlapat, Intragumtornchai, Tanin

“…Abstract 1411 Poster Board I-434 The prevalence and etiology of asymptomatic neutropenia in Asians are still unknown. Therefore, we conducted the epidemiologic…”
Get full text

Analysis of outcomes based on response for patients with relapsed or relapsed and refractory multiple myeloma in the phase 3 PANORAMA 1 study by Hungria, Vania T.M., San Miguel, Jesus F., Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A., Elghandour, Ashraf, Jedrzejczak, Wieslaw W., Guenther, Andreas, Na Nakorn, Thanyaphong, Siritanaratkul, Noppadol, Schlossman, Robert L., Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae Hoon, Einsele, Hermann, Sopala, Monika, Bengoudifa, Bourras-Rezki, Corrado, Claudia, Richardson, Paul G.

“…Abstract only…”
Get full text

Panobinostat plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who received prior bortezomib and IMiDs: A predefined subgroup analysis of PANORAMA 1 by San Miguel, Jesus F., Hungria, Vania T.M., Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A., Elghandour, Ashraf, Jedrzejczak, Wieslaw W., Guenther, Andreas, Na Nakorn, Thanyaphong, Siritanaratkul, Noppadol, Schlossman, Robert L., Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae Hoon, Einsele, Hermann, Sopala, Monika, Bengoudifa, Bourras-Rezki, Corrado, Claudia, Richardson, Paul G.

“…Abstract only…”
Get full text

Characterization of the Incidence and Management of Gastrointestinal Toxicity in the Phase 3 Panorama 1 Study of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma by Richardson, Paul G., Hungria, Vania T M, Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A., Elghandour, Ashraf, Jedrzejczak, Wieslaw Wiktor, Guenther, Andreas, Na Nakorn, Thanyaphong, Siritanaratkul, Noppadol, Schlossman, Robert L., Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae Hoon, Einsele, Hermann, Salwender, Hans, Sopala, Monika, Panneerselvam, Ashok, Redhu, Suman, Corrado, Claudia, Binlich, Florence, San Miguel, Jesus F.

“…▪ Introduction: In the randomized placebo controlled phase 3 trial PANORAMA 1 the pan-deacetylase inhibitor (pan-DACi) panobinostat combined with bortezomib…”
Get full text

Efficacy and Safety Based on Duration of Treatment of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma in the Phase 3 Panorama 1 Study by San Miguel, Jesus, Hungria, Vania TM, Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A., Elghandour, Ashraf, Jedrzejczak, Wieslaw Wiktor, Guenther, Andreas, Na Nakorn, Thanyaphong, Siritanaratkul, Noppadol, Schlossman, Robert L, Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae-Hoon, Einsele, Hermann, Salwender, Hans, Sopala, Monika, Redhu, Suman, Paul, Sofia, Corrado, Claudia, Binlich, Florence, Richardson, Paul G.

“…Introduction: Panobinostat (PAN) is a potent pan-deacetylase inhibitor (pan-DACi) that targets key aberrations in multiple myeloma (MM) cell biology, including…”
Get full text

Protein C and Protein S Levels Are Correlated with Bleeding Symptoms In Thai Population by Rojnuckarin, Ponlapat, Uaprasert, Noppacharn, Akkawat, Benjaporn, Nakorn, Thanyaphong Na, Intragumtornchai, Tanin

“…Abstract 3804 Hemostasis is maintained by a delicate balance between numerous activators and inhibitors. Present concept posits that mild bleeding phenotypes…”
Get full text

Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma by Rojnuckarin, Ponlapat, Nakorn, Thanyaphong Na, Assanasen, Thamathorn, Wannakrairot, Pongsak, Intragumtornchai, Tanin

“…Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare form of hematologic malignancy characterized by lesions in subcutaneous fat associated with…”
Get full text

Panorama 1: A randomized, double-blind, phase 3 study of panobinostat or placebo plus bortezomib and dexamethasone in relapsed or relapsed and refractory multiple myeloma by Richardson, Paul G., Hungria, Vania T.M., Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A., Elghandour, Ashraf, Jedrzejczak, Wieslaw W., Guenther, Andreas, Na Nakorn, Thanyaphong, Siritanaratkul, Noppadol, Schlossman, Robert L., Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae Hoon, Einsele, Hermann, Sopala, Monika, Bengoudifa, Bourras-Rezki, Corrado, Claudia, San-Miguel, Jesùs F.

“…Abstract only…”
Get full text